Zero Coupon Pharmacy DST

Other property — sponsored by Inland Private Capital

Minimum investment
$25k
Offering size
$4.4M
How much has sold
100.0%
Asset type
Other property
Location
Not stated
Financing
Zero coupon. Cash flow from the property goes to servicing the debt.

Sponsor-reported, from SEC filings and cited sources.

Chapter 1

What is this, in one paragraph?

Zero Coupon Pharmacy DST is a closed Inland Private Capital offering: a Delaware statutory trust (DST) holding fractional real estate interests for 1031 exchange investors.2 It sold to accredited investors — those meeting SEC income or net-worth tests — under a Form D private offering begun September 2012 and last amended January 2013. Filings never name the property; its zero-coupon structure directed rent to debt service rather than current distributions.

Show sources (5)Hide sources (5)

These links support the historical public record; individual details may come from different sources.

On a 45-day clock? Find day 45 and day 180 from the sale date, then come back to this record.

Chapter 2

What exactly is the property?

Public filings never identify the property. The initial Form D describes the securities only as beneficial interests in a Delaware statutory trust reflecting beneficial interests in real estate — no address, tenant, building size or acquisition detail appears anywhere in the record.2 Reviewed zero-coupon coverage points toward Inland's Pharmacy Portfolio III and IV programs, but no source links either name or any specific building to this Trust's filings.

Chapter 3

How did it end?

What happened

No ending on record

No public disposition announcement naming Zero Coupon Pharmacy DST (CIK 1558967) was located; the only IPC zero-coupon monetization press release (July 14, 2022) named Pharmacy Portfolio III DST and Pharmacy Portfolio IV DST, which do not match this trust's name on file with the SEC.

Reviewed public zero-coupon coverage identifies Pharmacy Portfolio III DST and Pharmacy Portfolio IV DST, but no source explicitly links either name or an underlying property to CIK 1558967; exact property details are not publicly confirmed.

Supporting evidence
Chapter 4

How is it financed, and what does it pay?

Zero-coupon — also called zero cash flow — financing means the loan is sized so that essentially all rent from the property services the debt, leaving investors little or no current income while principal amortizes over the loan term. Public filings for this Trust name no lender and disclose no loan balance.

Financing
Zero coupon. Cash flow from the property goes to servicing the debt.
Chapter 6

What does the paperwork say?

Six Form D notices run from September 2012 to January 2013, each amendment restating the running subscription figures, and nothing has been filed for this Trust since.3 Because it was sold privately without public advertising, no prospectus exists — the operative terms sit in the private placement memorandum (PPM).

  1. First Form D filedThe public offering record begins.
  2. Offering amount recordedA Form D amendment recorded offering and sales totals.
  3. Filing record updatedA later amendment updated the sponsor’s filing record.
  4. Latest Form D filedThe most recent sponsor-filed checkpoint in this record.
Filings on record
6
How it may be offered
Rule 506(b)Not advertised publicly. Offered through existing relationships.

A Form D is the notice a sponsor files when it starts raising money. A Form D filing does not mean the SEC approved, endorsed, or verified the offering.

DST interests are illiquid private securities. You may lose some or all of your investment. Distributions, tax treatment, and exit timing are not guaranteed. Review the current Private Placement Memorandum before investing.

Chapter 7

Common questions

What happened to Zero Coupon Pharmacy DST?

Top1031 lists Zero Coupon Pharmacy DST as historical. It is no longer raising money.

Where does Top1031 get the data for Zero Coupon Pharmacy DST?

Top1031 builds this record from the sponsor’s own SEC filings and cited sponsor disclosures. Filings can lag what is happening now. A Form D filing does not mean the SEC approved, endorsed, or verified the offering.

Can I still invest in Zero Coupon Pharmacy DST?

No. This Trust is closed to new investors. Its last SEC filing was a Form D amendment on January 29, 2013, and the offering is no longer raising capital. Investors looking at a current 45-day identification window would need to review Inland Private Capital's active offerings or other sponsors' current DSTs instead.

What does "zero coupon" mean in a DST?

A zero-coupon (or zero cash flow) DST is financed with a loan sized so that essentially all rent from the property goes to debt service. Investors typically receive little or no current cash distribution during the hold; the economics rest on principal amortization and whatever happens at sale, refinancing or loan maturity.

What property did this Trust own?

The public record does not say. The Form D filings describe only beneficial interests in a Delaware statutory trust reflecting interests in real estate, without an address, tenant or square footage.[2] The trust name suggests pharmacy retail, but no source located links a specific building or tenant to this filer.

Is this the same as Inland's Pharmacy Portfolio III or IV DST?

No source establishes that. Inland Private Capital's July 14, 2022 release on monetizing its first zero-coupon offerings names Pharmacy Portfolio III DST and Pharmacy Portfolio IV DST — different offering names from this Trust. Whether they share underlying assets is not something public filings settle.

Has the sponsor reported an outcome for this Trust?

No outcome specific to Zero Coupon Pharmacy DST has been reported in the sources reviewed. The SEC record for this filer ends with the January 29, 2013 Form D amendment, and no later disposition, refinancing or amendment for this exact entity was located as of August 17, 2026.

How was the offering sold?

Through a private placement to accredited investors — people meeting SEC income or net-worth thresholds — under Rule 506(b), which permits no general advertising or public solicitation. Subscriptions were reported to the SEC on Form D and its amendments rather than through a registered prospectus.